Skip to main content
. 2020 Nov 19;29:100651. doi: 10.1016/j.eclinm.2020.100651

Table 2.

Test performance of the different kits (equivocal results were excluded from the calculation of sensitivity and specificity and are not included in the sample size columns of the table).

Test Kit Negative Patients (n) % Specificity (95% CIe) Positive PCR ≥14d Patients (n) % Sensitivity (95% CIe)
Abbott 2382 99.5 (99.2–99.74) 588 84.7 (81.5–87.4)
Diasorin 2379a 98.7 (98.2–99.1) 562b 82.4 (79.0–85.3)
VIDAS IgG 1304 98.9 (98.2–99.4) 345 89.3 (85.5–92.1)
Roche 1516 100.0 (99.8–100.0) 489 89.0 (85.9–91.4)
ELISA 1209c 97.7 (96.7–98.4) 310d 89.4 (85.4–92.3)
Beckman 318 100.0 (98.8–100) 162 81.5 (74.6–86.6)
Siemens 432 99.8 (98.7–99.94) 156 85.9 (79.4–90.4)

a 8 equivocal results; b 20 equivocal results; c 19 equivocal results; d 1 equivocal result; e 95% confidence interval calculated using binomial distribution.